Alisertib, an AKA inhibitor associated with low IC50 in CRMM2 in our study, induced growth arrest and apoptosis in several skin melanoma cell lines [75], including resistant melanoma cell lines [78]. The gene discussed is NEUROG1; the disease is melanoma.